1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Analytical Tool - Protein Kinase Inhibitors in Oncology

Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2014*

The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies active in the development of PKIs in oncology
* Information on key industry related PKI drug projects in oncology
* Data from most important clinical trials
* Information on early developmental stage projects
* Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners & competitors
* Laying down a comprehensive framework for further analysis of the field
* Producing presentations surrounding the development of PKI drugs in oncology
* Identifying emerging PKI cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of PKI drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Protein Kinase Inhibitors in Oncology

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer

  • $ 695
  • Industry report
  • June 2015
  • by Firstword Pharma

Much of the debate around cancer immunotherapy at the recent ASCO annual meeting focused on the commercial positioning of a new class of product – the PD-1/PD-L1 inhibitors – in second-line, non-small-cell ...

Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential

Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential

  • $ 2 676
  • Industry report
  • July 2015
  • by Visiongain

Report Details Ovarian Cancer Therapies – Explore Potentials of New Drugs, Industry Changes and Emerging Opportunities What’s the future for treating cancer of the human ovaries? Visiongain’s new ...

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

  • $ 2 199
  • Industry report
  • July 2015
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues ...


Download Unlimited Documents from Trusted Public Sources

General Medicine And Specialty Medicine Industry in the US

  • July 2015
    11 pages
  • Oncology  

    Radiation Thera...  

    Chemotherapy  

  • United States  

View report >

Therapy Industry in the US

  • July 2015
    11 pages
  • Therapy  

    Cancer Therapy  

    Hepatitis B  

  • United States  

View report >

Oncology Industry in Australia - Forecast

  • June 2015
    4 pages
  • Oncology  

    Chemotherapy  

    Cancer  

  • Australia  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.